Raras
Buscar doenças, sintomas, genes...
Ceratoconjuntivite primaveril
ORPHA:70476CID-10 · H16.2CID-11 · 9A60.5DOENÇA RARA

A Ceratoconjuntivite Vernal (CV) é uma alergia grave e crônica que afeta a superfície dos olhos. Ela atinge principalmente meninos que vivem em climas quentes e secos. As crises de CV são comuns na primavera (época que dá nome à doença) e no verão, mas podem reaparecer no inverno. Os sinais e sintomas geralmente começam antes dos 10 anos e podem incluir: bolinhas duras, que parecem 'paralelepípedos' (chamadas papilas) na pálpebra superior; sensibilidade à luz; vermelhidão; secreção de muco pegajosa; e piscar involuntário ou espasmos da pálpebra (blefaroespasmo). A condição geralmente desaparece com o início da puberdade. É causada por uma reação alérgica a alérgenos presentes no ar. O tratamento tem como objetivo prevenir as 'crises' e aliviar os sintomas da doença.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

A Ceratoconjuntivite Vernal (CV) é uma alergia grave e crônica que afeta a superfície dos olhos. Ela atinge principalmente meninos que vivem em climas quentes e secos. As crises de CV são comuns na primavera (época que dá nome à doença) e no verão, mas podem reaparecer no inverno. Os sinais e sintomas geralmente começam antes dos 10 anos e podem incluir: bolinhas duras, que parecem 'paralelepípedos' (chamadas papilas) na pálpebra superior; sensibilidade à luz; vermelhidão; secreção de muco pegajosa; e piscar involuntário ou espasmos da pálpebra (blefaroespasmo). A condição geralmente desaparece com o início da puberdade. É causada por uma reação alérgica a alérgenos presentes no ar. O tratamento tem como objetivo prevenir as 'crises' e aliviar os sintomas da doença.

Pesquisas ativas
5 ensaios
25 total registrados no ClinicalTrials.gov
Publicações científicas
1.004 artigos
Último publicado: 2026 Apr 11

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
>1 / 1000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
151.0
Italy
Início
Childhood
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: H16.2
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

👁️
Olhos
10 sintomas
🦴
Ossos e articulações
1 sintomas
❤️
Coração
1 sintomas

+ 11 sintomas em outras categorias

Características mais comuns

90%prev.
Conjuntivite alérgica
Muito frequente (99-80%)
90%prev.
Morfologia anormal da córnea
Muito frequente (99-80%)
90%prev.
Neovascularização corneana
Muito frequente (99-80%)
90%prev.
Ceratoconjuntivite
Muito frequente (99-80%)
90%prev.
Epífora
Muito frequente (99-80%)
90%prev.
Hiperemia conjuntival
Muito frequente (99-80%)
23sintomas
Muito frequente (12)
Frequente (6)
Ocasional (4)
Muito raro (1)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 23 características clínicas mais associadas, ordenadas por frequência.

Conjuntivite alérgicaAllergic conjunctivitis
Muito frequente (99-80%)90%
Morfologia anormal da córneaAbnormal cornea morphology
Muito frequente (99-80%)90%
Neovascularização corneanaCorneal neovascularization
Muito frequente (99-80%)90%
CeratoconjuntiviteKeratoconjunctivitis
Muito frequente (99-80%)90%
EpíforaEpiphora
Muito frequente (99-80%)90%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico1.004PubMed
Últimos 10 anos200publicações
Pico202456 papers
Linha do tempo
2026Hoje · 2026🧪 2001Primeiro ensaio clínico📈 2024Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

🧬

Nenhum gene associado encontrado

Os dados genéticos desta condição ainda estão sendo catalogados.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
Aprovado3
3Fase 37
2Fase 21
1Fase 12
·Pré-clínico7
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 20 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Ceratoconjuntivite primaveril

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

1 pesquisa recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

25 ensaios clínicos encontrados, 5 ativos.

Distribuição por fase
NCT06913790 · Evaluation of Central Corneal Thickness in Patients With Ver…Ativo
NCT06903884 · 3% Diquafosol Ophthalmic Solution for Active Moderate-to-Sev…Em breve
PHASE3
NCT07138742 · Tacrolimus Eye Drops in Treatment of Vernal Keratoconjunctiv…Em breve
NA
NCT06746467 · Corneal Topography in Vernal KeratoconjunctivitisEm breve
NCT05353101 · Cyclosporine 0.05% Eye Drops for Vernal Keratoconjunctivitis…Concluído
PHASE1
NCT01751126 · Double-Masked Trial of NOVA22007 (1mg/mL Ciclosporin/Cyclosp…Concluído
PHASE3
NCT05076084 · Evaluation of the Efficacy and Safety of Tacrolimus Drops in…Concluído
NCT04705584 · Topical Immuonosuppressant Drugs in Spring CatarrhUNKNOWN
NA
NCT03379311 · A Study of AK002 in Patients With Atopic Keratoconjunctiviti…Concluído
PHASE1
NCT03557203 · Dermatologic Tacrolimus Ointment on Eyelids in the Treatment…UNKNOWN
NCT03464435 · A Novel Combined Therapy for Refractory Vernal Keratoconjunc…Concluído
PHASE4
NCT02456025 · Topical Tacrolimus in Vernal KeratoconjunctivitisUNKNOWN
PHASE4
NCT00567762 · Phase III Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspens…Concluído
PHASE3
NCT02057822 · Cytokine Assay in Tears of Healthy Children and With Vernal …UNKNOWN
NCT01211327 · Topical Cyclosporine for Vernal Keratoconjunctivitis (VKC) i…Concluído
PHASE4
NCT01068054 · Efficacy Study of FK-506 and Cyclosporine in Vernal Keratoco…Concluído
PHASE2, PHASE3
NCT00445120 · Lactobacillus Rhamnosus GG Oral Treatment Efficacy on Vernal…Concluído
PHASE2, PHASE3
NCT00426023 · Cyclosporin A Eye Drop Treatment in Vernal Keratoconjunctivi…Concluído
PHASE3
NCT00567918 · Phase III, Long-Term, Open-Label, Extension Study of 0.1% Ta…Concluído
PHASE3
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
478 papers (10 anos)
#1

Enigmatic Role of IL-31 in the Itch and Inflammation of Vernal Keratoconjunctivitis.

Juntendo medical journal2026

Vernal keratoconjunctivitis (VKC) is a recurrent allergic inflammation of the conjunctiva characterized by itchiness. The cytokine IL-31 is involved in itch and inflammation in other conditions, so we investigated whether it plays similar role in VKC. We estimated messenger RNA (mRNA) IL-31 expression in giant papillae (GP) with real-time polymerase chain reaction (RT-PCR). We used immunohistochemistry to examine IL-31 receptor (IL-31R) expression in neurons and epithelial cells in GP. We then performed fluorescence-activated cell sorting and immunofluorescence to examine IL-31R expression in cultured human conjunctival epithelial cells (HConEpiCs) either treated or not treated with various cytokines. Next, we examined the expression of phosphorylated signal transducer and activator of transcription 3 (P-STAT3) and suppressor of cytokine signaling 3 (SOCS3) in the epithelium of GP and control specimens using immunohistochemistry. Last, we used DNA microarray analysis and RT-PCR to investigate whether recombinant IL-31 induced expression of various genes in HConEpiCs. IL-31 expression was elevated in GP compared with control specimens. Although many neuron fibers innervated GP, none was found to express IL-31R. IL-31R was expressed in the epithelium of GP and in HConEpiCs, and its expression in HConEpiCs was not altered by any of the investigated cytokines. Recombinant IL-31 increased SOCS3 mRNA expression. Strong P-STAT3 expression was observed in the epithelium of GP, but SOCS3 expression was not observed. Increased IL-31 in GP of VKC patients may not directly influence itch sensation via neuron fibers and inflammation via the expression of P-STAT3 and SOCS3.

#2

Effectiveness of Corticosteroid-Sparing Topical Treatments for Vernal Keratoconjunctivitis in Children: A Report by the American Academy of Ophthalmology.

Ophthalmology2026 Mar 09

To review the published literature assessing the efficacy of corticosteroid-sparing topical treatments for vernal keratoconjunctivitis (VKC) in children 18 years of age and younger. A literature search of the PubMed database was last conducted in August 2025 and limited to articles published in English without date restrictions. The search yielded 56 articles, which were reviewed by the primary author in abstract form; 24 were selected for full-text review. Fifteen articles met the inclusion criteria and were assigned a level of evidence rating by the panel methodologist. Six studies were rated level I, and 9 studies were rated level III. Level I evidence evaluated the efficacy of cyclosporine (4/6), tacrolimus (4/6), interferon alpha-2b (1/6), and sodium cromoglycate (1/6) ophthalmic preparations. Most level III evidence studies (5/9) reported outcomes using tacrolimus drops or ointment. Regardless of the medication, concentration, dosing frequency, or treatment duration, level I and level III evidence included in the assessment demonstrated that signs and symptoms of VKC in children can be improved with intervention. Apart from application site discomfort, the studies reported no significant adverse events. Level I and III evidence demonstrate that treatment with corticosteroid-sparing topical interventions such as cyclosporine, tacrolimus, sodium cromoglycate, and interferon alpha-2b can improve clinical signs and symptoms of VKC in children. Most of the level I evidence supports the use of the calcineurin inhibitors-cyclosporine and tacrolimus. Proprietary or commercial disclosure may be found after the references.

#3

Changing Strategies in Keratoplasty After Corneal Hydrops: From Penetrating to Lamellar Approaches - A Narrative Review.

Clinical ophthalmology (Auckland, N.Z.)2026

The hallmark of acute corneal hydrops (CH) is Descemet membrane (DM) rupture that leads to the influx of fluid into the cornea causing corneal edema. Multiple risk factors have been related to an increased incidence of CH in keratoconus (KC) patients, such as Down's syndrome, atopy, vernal keratoconjunctivitis, eye rubbing, and an earlier age of KC onset. Penetrating keratoplasty (PKP), deep anterior lamellar keratoplasty (DALK), compression sutures, cyanoacrylate tissue adhesive with bandage contact lens (BCL), intracameral gas injection, and amniotic membrane transplant (AMT) are some of the conservative and surgical methods used to treat CH. Compared to KC without a history of CH, the need for PKP in patients with healed hydrops is higher due to preexisting DM rupture. Thus, the majority of surgeons conduct PKP after CH. On the other hand, some corneal surgeons choose to perform DALK over PKP as it spares the host endothelium. In this narrative review, we compare DALK to PKP for corneal hydrops in KC, evaluating the challenges, advantages, and visual and refractive outcomes.

#4

Corneal collagen cross-linking at diagnosis in pediatric keratoconus: A prospective study from the Indian Subcontinent.

Indian journal of ophthalmology2026 Feb 11

To assess the one-year visual, refractive, and tomographic outcomes of corneal collagen cross-linking (CXL) performed at diagnosis in Indian children with keratoconus and to evaluate its safety in eyes with controlled vernal keratoconjunctivitis (VKC). Thirty-eight eyes of 30 children (9-18 years) diagnosed with keratoconus underwent standard epithelium-off CXL (Dresden protocol). "At diagnosis" was defined as treatment within four weeks of first topographic confirmation. Outcome measures included uncorrected visual acuity (UCVA), best spectacle-corrected visual acuity (BCVA), mean refractive spherical equivalent (MRSE), keratometric indices (flat K, steep K, apical K), pachymetry, and endothelial cell density. Statistical analysis included paired and adjusted comparisons with 95% confidence intervals (CIs). UCVA improved from 0.72 ± 0.46 to 0.45 ± 0.42 logMAR (P < 0.001) and BCVA from 0.37 ± 0.30 to 0.21 ± 0.28 logMAR (P < 0.001). MRSE improved by 1.72 D (P < 0.001). Steep K and apical K flattened by 2.02 D and 2.26 D respectively (P < 0.001). Endothelial cell counts were stable. Subgroup analysis showed no difference between VKC and non-VKC eyes. Three patients developed transient sterile infiltrates that resolved with medical therapy. Performing CXL at diagnosis is safe and effective in halting pediatric keratoconus progression while improving visual and refractive outcomes. Early treatment is particularly relevant for high-risk ethnic groups such as Indian children, where keratoconus is aggressive and rapidly progressive.

#5

Factors associated with graft astigmatism after corneal transplantation for keratoconus.

BMC ophthalmology2026 Feb 06

Graft astigmatism remains a major impediment to early visual rehabilitation and the long-term success of keratoplasty. Previous studies have identified graft size, donor–recipient size discrepancy, timing of suture removal, and surgical indication as factors associated with postoperative graft astigmatism. However, these studies often included heterogeneous corneal pathologies and evaluated the effects of only one or a limited number of variables. The present study aimed to investigate factors associated with corneal graft astigmatism following corneal transplantation in a large cohort of patients with keratoconus. This retrospective, comparative interventional case series included 646 consecutive corneal transplants performed in 556 patients with keratoconus. Of these, 338 eyes underwent penetrating keratoplasty and 308 eyes underwent deep anterior lamellar keratoplasty. Postoperative keratometric astigmatism was assessed 3 to 12 months after complete suture removal. Generalized linear models were used to evaluate preoperative, intraoperative, and postoperative factors associated with postoperative keratometric astigmatism. The mean age at the time of keratoplasty was 29.3 ± 8.8 years. The mean postoperative keratometric astigmatism was 4.78 ± 2.24 D (range, 0.0–14.0 D). Increasing patient age (β = 0.05, P < 0.001) and a prior history of vernal keratoconjunctivitis (β = 0.49, P = 0.03) were significantly associated with greater postoperative keratometric astigmatism. Keratometric astigmatism was significantly higher in patients older than 30 years at the time of corneal transplantation. Deep anterior lamellar keratoplasty was associated with lower postoperative keratometric astigmatism during the second study period (β=−0.80, P = 0.008), when this technique was predominantly performed. Other variables, including keratoconus severity (P = 0.10), donor age (P = 0.10), graft rating (P = 0.37), donor trephine size (P = 0.27), donor–recipient disparity (P = 0.54), suturing technique (P = 0.88), selective suture removal (P = 0.07), duration of corticosteroid therapy (P = 0.70), time to complete suture removal (P = 0.30), and suture-related complications (P = 0.77), were not significantly associated with postoperative graft astigmatism. Age at the time of keratoplasty, a history of vernal keratoconjunctivitis, and possibly the keratoplasty technique were associated with postoperative graft astigmatism. Other intraoperative and postoperative variables were not significantly associated with keratometric astigmatism following corneal transplantation in patients with keratoconus. Why carry out this study? What was learned from the study? Graft astigmatism is the major impediment to early visual rehabilitation and the ultimate success of the keratoplasty. Previous studies have identified graft size, donor-recipient size discrepancy, time of suture removal, and the indications of keratoplasty as factors associated with graft astigmatism. These studies, however, included heterogeneous corneal pathologies and considered the effect of one or a few factors at the time. The present study evaluated the influence of various preoperative, intraoperative, and postoperative factors on post-keratoplasty keratometric astigmatism in a large number of keratoconus patients. Patient age, history of vernal keratoconjunctivitis, and, possibly, corneal transplantation technique were significantly correlated with post-keratoplasty keratometric astigmatism. Graft astigmatism had no association with keratoconus severity, donor age, graft rating, donor trephine size, suturing technique, duration of corticosteroid application, or time to complete suture removal.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC618 artigos no totalmostrando 198

2026

Enigmatic Role of IL-31 in the Itch and Inflammation of Vernal Keratoconjunctivitis.

Juntendo medical journal
2026

Effectiveness of Corticosteroid-Sparing Topical Treatments for Vernal Keratoconjunctivitis in Children: A Report by the American Academy of Ophthalmology.

Ophthalmology
2026

[Regeneration potential and remodelling of juvenile cornea resulting from vernal keratoconjunctivitis].

Die Ophthalmologie
2026

Changing Strategies in Keratoplasty After Corneal Hydrops: From Penetrating to Lamellar Approaches - A Narrative Review.

Clinical ophthalmology (Auckland, N.Z.)
2026

Corneal collagen cross-linking at diagnosis in pediatric keratoconus: A prospective study from the Indian Subcontinent.

Indian journal of ophthalmology
2026

Factors associated with graft astigmatism after corneal transplantation for keratoconus.

BMC ophthalmology
2026

Ocular Allergy Within the Framework of the EAACI Nomenclature of Allergic Diseases and Hypersensitivity Reactions.

Allergy, asthma &amp; immunology research
2026

Comparative Analysis of Inflammatory Mediators in Children, Adolescents, and Adults with Vernal Keratoconjunctivitis.

Seminars in ophthalmology
2026

Comprehensive assessment of tear film dynamics in pediatric vernal keratoconjunctivitis using a novel non-invasive device (MYAH).

Contact lens &amp; anterior eye : the journal of the British Contact Lens Association
2025

Exploring the Gut-Eye Axis: Microbial Dysbiosis in Vernal Keratoconjunctivitis.

Cornea
2025

Pediatric Ocular Surface Inflammatory Diseases: Clinical Features and Practice Patterns.

Cornea
2025

Artificial Intelligence-Powered Interpretation of Corneal Epithelial Maps: A Comparative Pilot Study of ChatGPT, Google Gemini, and Microsoft Bing.

Cureus
2025

Splendore-Hoeppli phenomenon in vernal keratoconjunctivitis: a rare photographic documentation in a paediatric case.

Eye (London, England)
2025

An update in vernal keratoconjunctivitis.

Indian journal of ophthalmology
2025

Predictive Factors of Suboptimal Response to Topical 0.1% Cyclosporine A Cationic Emulsion in Pediatric Vernal Keratoconjunctivitis: A Real-World Retrospective Study.

Ophthalmology and therapy
2025

Outcomes of Collagen Crosslinking in Patients with Keratoconus and Co-Existent Limbal Stem Cell Deficiency.

Clinical ophthalmology (Auckland, N.Z.)
2025

Risk Factors Associated With Steroid-Induced Ocular Hypertension and Glaucoma in Patients With Vernal Keratoconjunctivitis in a North Indian Population: A Multicenter Study.

Cureus
2025

Long-Term Outcomes of Deep Anterior Lamellar Keratoplasty in Pediatric Keratoconus: A 15-Year Retrospective Analysis.

Cornea
2025

Challenges in the management of microsporidial keratoconjunctivitis: recurrent infection and environmental contamination.

BMJ case reports
2025

Decoding Allergic Conjunctivitis: Latest Perspectives on Etiological Drivers and Immunopathological Mechanisms.

Clinical reviews in allergy &amp; immunology
2026

Surgical Management of Corneal Sequelae of Vernal Keratoconjunctivitis.

Seminars in ophthalmology
2025

Keratoconus and quality of life: an updated comprehensive review.

BMC ophthalmology
2026

"Ocular Surface Disorders in Children": A Comprehensive Review of Pathogenesis, Diagnosis, and Management.

Seminars in ophthalmology
2025

The impact of tacrolimus therapy on the outcomes of vernal keratoconjunctivitis: a systematic review and meta-analysis.

Frontiers in medicine
2025

Topical Use of Tacrolimus in Corneal and Ocular Surface Pathologies: A Systematic Review.

Journal of clinical medicine
2025

Association of Serum Vitamin D, IgE, Eosinophils, and Time Spent Outdoor During Daylight with Disease Severity in Vernal Keratoconjunctivitis.

Ocular immunology and inflammation
2025

Where eye meets body part 2: uniting allergy pathways in ocular and atopic disease - T cells take the lead.

Current opinion in allergy and clinical immunology
2026

Tomographic and biomechanical refractive findings in ocular pediatric allergy.

Japanese journal of ophthalmology
2025

Shield ulcer in keratoconus in the absence of atopic or vernal kerato-conjunctivitis.

GMS ophthalmology cases
2026

Recent Advances in Targeted Immunomodulatory Therapies for Chronic Ocular Surface Diseases.

Seminars in ophthalmology
2025

Mapping the Future: Anterior Segment OCT for Corneal Epithelial Thickness in Vernal Keratoconjunctivitis.

Maedica
2025

Tacrolimus Ophthalmic Suspension Can Be an Effective Treatment Option for Biologic-Induced Refractory Conjunctivitis.

Cureus
2026

Prevalence of vernal keratoconjunctivitis in Canada: a cross-sectional survey study.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie
2025

The psychological impact of vernal keratoconjunctivitis on families: An investigation on quality of life and psychological wellbeing.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
2025

Efficacy of supratarsal traimcinolone injection in the treatment of recalcitrant vernal keratoconjunctivitis.

Pakistan journal of pharmaceutical sciences
2025

Vernal Keratoconjunctivitis: Impact on Children.

Eye &amp; contact lens
2026

The Role of Topical Cyclosporine A in Ocular Surface Inflammatory Disorders.

Seminars in ophthalmology
2025

Ocular Manifestations in Children with Vernal Keratoconjunctivitis.

Children (Basel, Switzerland)
2025

Steroid-Induced Ocular Hypertension in Children: A Review on Risk Factors.

Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
2025

The evolving role of ciclosporin in the management of vernal keratoconjunctivitis.

Frontiers in ophthalmology
2025

The burden of antimicrobial resistance in biofilm forming Staphylococcus spp. from Vernal Keratoconjunctivitis patients eyes.

Biofilm
2025

Evaluating the Efficacy of Artificial Intelligence-Driven Chatbots in Addressing Queries on Vernal Conjunctivitis.

Cureus
2025

Vernal keratoconjunctivitis in human immunodeficiency positives: A case series.

Indian journal of ophthalmology
2025

Unpacking VKC: How gender and age shape the clinical picture.

Indian journal of ophthalmology
2025

Immunophenotyping in Vernal Keratoconjunctivitis: Schirmer Test for Therapy Response Prediction.

Allergy
2024

Topical tacrolimus versus dexamethasone in managing shield ulcer of vernal keratoconjunctivitis.

Medical hypothesis, discovery &amp; innovation ophthalmology journal
2025

Vernal keratoconjunctivitis: The burden of being allergic.

The journal of allergy and clinical immunology. Global
2025

Progress of Research and Comparative Analysis on the Combination of Mast Cell Stabilizers and Antihistamines in Allergic Conjunctivitis Treatment.

Ocular immunology and inflammation
2024

Efficacy and Safety of Topical Tacrolimus for Vernal Keratoconjunctivitis: A Systematic Review.

Beyoglu eye journal
2025

Managing Bilateral Vernal Keratoconjunctivitis, Keratoconus, and Steroid-Induced Glaucoma: A Threefold Struggle.

Cureus
2025

Corneal Degeneration Secondary to Vernal Keratoconjunctivitis.

JAMA ophthalmology
2025

Corticosteroid-sparing topical treatment with cyclosporin for juvenile keratoconjunctivitis.

Scientific reports
2025

Insights from 1096 clinical cases: pioneering a universal grading system for vernal keratoconjunctivitis management.

The British journal of ophthalmology
2025

Oral Cyclosporine in Vernal Keratoconjunctivitis: Indications, Outcomes, and Effect on Corticosteroid Use.

Cornea
2024

The Role of In Vivo Confocal Microscopy in Ocular Allergies.

Turkish journal of ophthalmology
2025

Epidemiological insights into Childhood vernal keratoconjunctivitis in India: Unravelling clinical presentation and environmental influences - The EPIC VKC study - Fourth report of the ICMR EYE SEE study group.

The ocular surface
2024

Efficacy of Epinastine Eyelid Cream in Pediatric Vernal Keratoconjunctivitis: A Case Report.

Cureus
2025

An evaluation of corneal topographic changes in a large series of patients with vernal keratoconjunctivitis.

Journal francais d'ophtalmologie
2025

Serum Vitamin D Levels in Patients with Vernal Keratoconjunctivitis: A Systematic Review and Meta-Analysis.

Ocular immunology and inflammation
2024

EFFICACY OF TRANSEPITHELIAL ACCELERATED COLLAGEN CROSS LINKING IN STOPPING THE PROGRESSION OF KERATOCONUS.

Journal of Ayub Medical College, Abbottabad : JAMC
2025

Oral mucous membrane tarsal patch grafting: broadening indications and long-term outcomes.

Orbit (Amsterdam, Netherlands)
2024

Efficacy of a Cationic Emulsion of Cyclosporine in Moderate Vernal Keratoconjunctivitis: Erratum.

Cornea
2024

Pediatric keratoconus in a tertiary eye hospital in Eastern province, Saudi Arabia: Patient characteristics and management outcomes.

Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society
2025

Rasch analysis of quality of life in children with vernal keratoconjunctivitis (QUICK) questionnaire.

Clinical &amp; experimental optometry
2025

Challenging corneal diseases and microRNA expression: Focus on rare diseases and new therapeutic frontiers.

Survey of ophthalmology
2024

Seeing eye to eye: a modified Delphi method-based multidisciplinary expert consensus on the diagnosis and treatment of vernal keratoconjunctivitis.

European journal of pediatrics
2025

Association Between Pterygium and Ocular, Periocular, and Systemic Inflammatory Conditions: A Large-Scale National Study.

Cornea
2025

Tear film parameters and meibography in eyes of children with vernal keratoconjunctivitis.

Indian journal of ophthalmology
2024

Allergen Testing: A Review of the Indications, Procedures, and Limitations in Ocular Allergy.

Clinical reviews in allergy &amp; immunology
2024

Long-Term Observation of Prognostic Factors and Clinical Outcome of Vernal Keratoconjunctivitis in Childhood.

Clinical ophthalmology (Auckland, N.Z.)
2024

Screening Preadolescents for Keratoconus Risk Factors in a Low-Resource Setting.

Eye &amp; contact lens
2025

Use of explainable AI on slit-lamp images of anterior surface of eyes to diagnose allergic conjunctival diseases.

Allergology international : official journal of the Japanese Society of Allergology
2024

Health-related Quality of Life in Children with Vernal Keratoconjunctivitis in Malaysia.

Korean journal of ophthalmology : KJO
2024

Combined Papillectomy and Autologous Conjunctival Membrane Graft as Management of Giant Papillae for Severe, Refractory Palpebral Vernal Keratoconjunctivitis-A Case Report.

Case reports in ophthalmological medicine
2024

Unraveling the complexity - Insights and interventions of refractory vernal keratoconjunctivitis.

The ocular surface
2024

Central corneal thickness and topographic indices in Malaysian children with vernal keratoconjunctivitis.

The Medical journal of Malaysia
2024

Topical Tacrolimus in Anterior Segment Disorders in Ophthalmology: A Review.

Romanian journal of ophthalmology
2024

JACQLQ subjective symptom questionnaire score and clinical test results for patients with allergic conjunctival disease.

Scientific reports
2024

Evaluation of Meibomian Gland Structure and Function in Patients with Vernal Keratoconjunctivitis Using Non Contact Meibography and Lipid Layer Interferometry.

Ocular immunology and inflammation
2024

Vernal keratoconjunctivitis in adults: a narrative review of prevalence, pathogenesis, and management.

Frontiers in ophthalmology
2025

Systemic Treatment With Cyclosporine A in Children With Severe Vernal Keratoconjunctivitis.

Cornea
2024

A Case of Refractory Vernal Keratoconjunctivitis Showing Improvement after the Administration of Upadacitinib for the Treatment of Atopic Dermatitis.

Diagnostics (Basel, Switzerland)
2024

Reversal of Peripheral Anterior Synechiae After Trabeculectomy With Argon Laser Synechiolysis.

Cureus
2024

Serum vitamin D levels in children with vernal keratoconjunctivitis - A study from a tertiary care pediatric hospital of North India.

Indian journal of ophthalmology
2024

Anti-interleukin 5 for treating severe refractory vernal keratoconjunctivitis in children: Two cases.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
2024

Treatment of Vernal Keratoconjunctivitis Using Upadacitinib.

JAMA ophthalmology
2024

Translation, adaptation, and psychometric properties of the Brazilian-Portuguese version of the Quality of Life in Children with Vernal Keratoconjunctivitis questionnaire.

Arquivos brasileiros de oftalmologia
2024

Endoplasmic Reticulum Stress and Unfolded Protein Response in Vernal Keratoconjunctivitis.

Investigative ophthalmology &amp; visual science
2024

Vernal Keratoconjunctivitis: Immunopathological Insights and Therapeutic Applications of Immunomodulators.

Life (Basel, Switzerland)
2024

Applications of topical immunomodulators enhance clinical signs of vernal keratoconjunctivitis (VKC) and atopic keratoconjunctivitis (AKC): a meta-analysis.

International ophthalmology
2025

Evaluation of Autophagy in Conjunctival Fibroblasts.

Methods in molecular biology (Clifton, N.J.)
2024

Limbal stem cell deficiency: Demography, aetiology, and clinical presentation in Eastern India.

Journal of family medicine and primary care
2024

Reserve drug as first-line management: Topical interferon α-2b for vernal keratoconjunctivitis.

Indian journal of ophthalmology
2024

Prevalence and risk factors of Vernal Keratoconjunctivitis among a Ghanaian clinical cohort: A case-control study.

Health science reports
2024

A Patient-Centered Approach to Vernal Keratoconjunctivitis (VKC): A Podcast.

Ophthalmology and therapy
2024

Tacrolimus Ointment in Periorbital Atopic Dermatitis.

Cureus
2024

Ocular surface squamous neoplasia masquerading as pseudoepitheliomatous hyperplasia in chronic vernal keratoconjunctivitis.

GMS ophthalmology cases
2024

Diagnosis and Treatment of Vernal Keratoconjunctivitis: A Qualitative Study of Caregiver, Patient, and Clinician Experience in the United States.

Journal of pediatric ophthalmology and strabismus
2024

[New and future treatment approaches for allergic conjunctivitis].

Die Ophthalmologie
2024

[Current aspects of vernal and atopic keratoconjunctivitis].

Die Ophthalmologie
2024

Burden of Vernal Keratoconjunctivitis in the United States: A Retrospective Claims Database Analysis.

Ophthalmology
2024

Accelerated Corneal Cross-linking in Pediatric Patients with Progressive Keratoconus: 12-Month Follow-up Results.

Nigerian journal of clinical practice
2024

Vernal keratoconjunctivitis and eosinophilic esophagitis: A rare combination?

The World Allergy Organization journal
2024

Visual outcome and postoperative complications of cataract surgery in patients with ocular surface disorders.

Journal of cataract and refractive surgery
2023

Long-Term Clinical Outcome of Tacrolimus Skin Ointment (0.03%) for the Treatment of Vernal Keratoconjunctivitis: A Quasi-Experimental Study.

Cureus
2024

Are inflammation-related diseases risk factors for primary acquired nasolacrimal duct obstruction? A large scale, national case-control study.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
2024

[Shield ulcer in vernal keratoconjunctivitis].

Die Ophthalmologie
2023

A Rare Case of Non-Neurological Ptosis.

Cureus
2024

Ocular surface pseudoepitheliomatous hyperplasia secondary to allergic eye disease: clinical features and management.

Eye (London, England)
2024

A rare case of acute stromal rejection following deep anterior lamellar keratoplasty in a steroid responder with keratoconus and vernal keratoconjunctivitis.

Indian journal of ophthalmology
2024

Epidemiology of Pediatric Ocular Surface Inflammatory Diseases in the United States Using the Optum Labs Data Warehouse.

Ophthalmology
2023

Usability of an Eye Drop Delivery Aid for Single-Dose Instillation: Results from a Market Research Study.

Clinical ophthalmology (Auckland, N.Z.)
2023

Axenfeld-Reiger syndrome: A search for the missing links.

World journal of clinical cases
2023

Prevalence and clinical profile of keratoconus in patients presenting at a provincial hospital in KwaZulu, Natal, South Africa: A case study.

Journal of public health in Africa
2024

Suture-related complications after deep anterior lamellar keratoplasty for keratoconus.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
2023

Classification of Subtypes of Vernal Keratoconjunctivitis by Cluster Analysis Based on Clinical Features.

Clinical ophthalmology (Auckland, N.Z.)
2024

Tear Tacrolimus Levels and Clinical Response After Adjunct Therapy With Cutaneous Application of Tacrolimus 0.1% Over Upper Eyelid Skin in Chronic Vernal Keratoconjunctivitis.

Cornea
2023

Dendritic Cell Density and Morphology Can Be Used to Differentiate Vernal Keratoconjunctivitis from Allergic Conjunctivitis.

Biomolecules
2024

Management of vernal keratoconjunctivitis: Navigating a changing treatment landscape.

Survey of ophthalmology
2023

Biomarkers of ocular allergy and dry eye disease.

Romanian journal of ophthalmology
2023

NOVATIVE: A Phase II/III, Multicenter, Double-masked, Randomized Study of Cyclosporine A 0.05% and 0.1% Ophthalmic Cationic Emulsion Versus Vehicle in Patients with Vernal Keratoconjunctivitis.

Clinical therapeutics
2024

Eosinophil extracellular trap formation in the giant papillae of atopic keratoconjunctivitis and vernal keratoconjunctivitis.

Allergology international : official journal of the Japanese Society of Allergology
2023

Two cases of unilateral limbal Vernal keratoconjunctivitis in the same family: first case report.

Frontiers in pediatrics
2023

Paediatric cornea crosslinking current strategies: A review.

Advances in ophthalmology practice and research
2024

Correlation between gene expression and clinical scores in vernal keratoconjunctivitis.

Allergy
2024

Efficacy of a Cationic Emulsion of Cyclosporine in Moderate Vernal Keratoconjunctivitis.

Cornea
2023

Vernal Keratoconjunctivitis: A Systematic Review.

Clinical reviews in allergy &amp; immunology
2022

Safety and efficacy of topical tacrolimus 0.03% in the management of vernal keratoconjunctivitis: a non-randomized controlled clinical trial.

Medical hypothesis, discovery &amp; innovation ophthalmology journal
2023

Association between keratoconus and allergic conjunctivitis in children attending a Tertiary Hospital in Nigeria.

Romanian journal of ophthalmology
2023

Surgical Treatment of Corneal Shield Ulcer in Vernal Keratoconjunctivitis: A Systematic Review.

Journal of personalized medicine
2023

Impact of Exposomes on Ocular Surface Diseases.

International journal of molecular sciences
2023

Air Pollution and Meteorological Conditions Significantly Associated With Vernal Keratoconjunctivitis Exacerbations.

Investigative ophthalmology &amp; visual science
2023

Prevalence and clinical characteristics of vernal keratoconjunctivitis in sub-Saharan Africa.

Current opinion in allergy and clinical immunology
2023

Vernal keratoconjunctivitis: Current immunological and clinical evidence and the potential role of omalizumab.

The World Allergy Organization journal
2023

Repeat deep anterior lamellar keratoplasty (DALK) for failed primary DALK.

Indian journal of ophthalmology
2023

Are Periocular and Systemic Allergy Conditions Risk Factors for Pterygium?

Seminars in ophthalmology
2023

Diagnostic criteria of chronic conjunctivitis: atopic keratoconjunctivitis and vernal keratoconjunctivitis.

Current opinion in allergy and clinical immunology
2023

Comparision of efficacy and safety of 0.03% and 0.1% tacrolimus ointment in children with vernal keratoconjunctivitis.

Therapeutic advances in ophthalmology
2023

A survey-based study on diagnosis and management of vernal keratoconjunctivitis.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
2023

Vernal Keratoconjunctivitis among Patients Presenting to the Outpatient Department of Ophthalmology of a Tertiary Care Centre: A Descriptive Cross-sectional Study.

JNMA; journal of the Nepal Medical Association
2023

Assessment of the efficacy of olopatadine 0.1% in the treatment of vernal keratoconjunctivitis in terms of clinical improvement based on total ocular symptom score and ocular surface disease index.

Indian journal of ophthalmology
2023

An observational study on the presence of perilimbal conjunctival pigmentation in vernal keratoconjunctivitis.

Indian journal of ophthalmology
2023

Cyclosporine ophthalmic emulsion (Verkazia) for vernal keratoconjunctivitis.

The Medical letter on drugs and therapeutics
2023

Vernal Keratoconjunctivitis Associated with Terrien Degeneration and Intralesional Cysts.

Ophthalmology
2024

Analysis of the outcomes of three different cross-linking protocols for treatment of paediatric keratoconus: A multicentre randomized controlled trial.

Acta ophthalmologica
2023

Artificial intelligence-based ChatGPT chatbot responses for patient and parent questions on vernal keratoconjunctivitis.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
2023

Splinter Cataract in Patients with Keratoconus and Frequent Eye Rubbing: A Novel Finding.

The American journal of case reports
2024

Corneal topometric indices and proclivity toward corneal ectasia in vernal keratoconjunctivitis.

Journal francais d'ophtalmologie
2023

Galectin-3, a damage-associated molecular pattern, in tears of patients with vernal keratoconjunctivitis.

Japanese journal of ophthalmology
2023

Clinical Outcomes of Topical 0.1% Ciclosporin Cationic Emulsion Used on Label in Children with Vernal Keratoconjunctivitis.

Ophthalmology and therapy
2023

Prevalence of dry eye disease in the patients of allergic conjunctivitis: Hospital-based cross-sectional study.

Indian journal of ophthalmology
2023

Evaluation of dry eyes in children with vernal kerato-conjunctivitis using clinical tests and ocular surface analysis.

Indian journal of ophthalmology
2024

Characteristics of Vernal Keratoconjunctivitis in Lhasa: A Single-Center, Observational Study.

Ocular immunology and inflammation
2023

Risk Factors Associated with Keratoconus in an Iranian Population.

Journal of ophthalmic &amp; vision research
2023

Vernal keratoconjunctivitis in Down syndrome: a case report.

BMC ophthalmology
2023

Tear Film MicroRNAs as Potential Biomarkers: A Review.

International journal of molecular sciences
2023

Clinical Study on Corneal Topographical Changes in Vernal Keratoconjunctivitis by Using OCULUS Pentacam®.

Cureus
2023

Novel Insights in the Management of Vernal Keratoconjunctivitis (VKC): European Expert Consensus Using a Modified Nominal Group Technique.

Ophthalmology and therapy
2023

Increased dendritic cell density and altered morphology in allergic conjunctivitis.

Eye (London, England)
2023

Diagnosis and management of keratoconus by eye care practitioners in Kenya.

BMC ophthalmology
2022

Demographic and clinical characteristics of childhood and adult onset Vernal Keratoconjunctivitis in a tertiary care center during Covid pandemic: A prospective study.

Romanian journal of ophthalmology
2023

Practice patterns and opinions in the treatment of allergic eye disease: A survey among Indian ophthalmologists.

Indian journal of ophthalmology
2022

Role of Oncostatin M in the Pathogenesis of Vernal Keratoconjunctivitis: Focus on the Barrier Function of the Epithelium and Interleukin-33 Production by Fibroblasts.

Investigative ophthalmology &amp; visual science
2023

Topical cyclosporine A cationic ophthalmic emulsion in paediatric vernal keratoconjunctivitis: pooled analysis of randomised NOVATIVE and VEKTIS trials.

Eye (London, England)
2023

Corneal biomechanical properties in vernal keratoconjunctivitis and its subtypes: a preliminary study.

International ophthalmology
2023

Paradoxical increase in peripapillary retinal nerve fibre layer thickness during the acute phase of steroid-induced increase in intraocular pressure in a patient with vernal keratoconjunctivitis.

Acta ophthalmologica
2023

Evaluation of corneal epithelial thickness mapping using anterior segment OCT in children with vernal keratoconjunctivitis.

International ophthalmology
2022

A Case of Vernal Keratoconjunctivitis With Growth Hormone Deficiency.

Cureus
2023

Evaluation of the factors that influence surgical outcome in conjunctival-limbal allograft transplantation.

Eye (London, England)
2022

Tissue remodeling in adult vernal keratoconjunctivitis.

Experimental eye research
2023

Biologics for allergy: therapeutic potential for ocular allergic diseases and adverse effects on the eye.

Allergology international : official journal of the Japanese Society of Allergology
2022

Efficacy and Safety of 0.1% Cyclosporine versus 2% Cyclosporine in the Treatment of Severe Vernal Keratoconjunctivitis in Children.

Clinical ophthalmology (Auckland, N.Z.)
2022

Efficacy of single dose dermatological 0.1% Tacrolimus Ointment in the treatment of vernal keratoconjunctivitis.

JPMA. The Journal of the Pakistan Medical Association
2022

Ocular surface characteristics in pediatric vernal keratoconjunctivitis: a clinico-cytological study.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
2022

The effect of COVID-19 imposed lockdown on Italian children with Vernal Keratoconjunctivitis.

The World Allergy Organization journal
2022

Executive summary: Japanese guidelines for allergic conjunctival diseases 2021.

Allergology international : official journal of the Japanese Society of Allergology
2022

The multifaceted aspects of ocular allergies: Phenotypes and endotypes.

The ocular surface
2022

Analysis of Cytokine Production Profiles of Local and Systemic Lymphocytes in Sick Building Syndrome Compared with Ocular Allergy.

Journal of asthma and allergy
2021

Impression Cytology Screening for Ocular Surface changes in various forms of Vernal Keratoconjunctivitis in Subtropical Central Zone in India.

Nepalese journal of ophthalmology : a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society : NEPJOPH
2022

Diagnosis, Management, and Treatment of Vernal Keratoconjunctivitis in Asia: Recommendations From the Management of Vernal Keratoconjunctivitis in Asia Expert Working Group.

Frontiers in medicine
2022

Emerging therapies targeting eosinophil-mediated inflammation in chronic allergic conjunctivitis.

The ocular surface
2023

Effect of Anti-allergic Therapy on Quality of Life in Children with Allergic Conjunctivitis and Their Parents.

Ocular immunology and inflammation
2023

Efficacy and Satisfaction of Cyclosporine 0.1% in Patients with Vernal Keratoconjunctivitis.

Ocular immunology and inflammation
2023

Effects of Antihistamine-Releasing Contact Lenses on Severe Allergic Conjunctivitis.

Ocular immunology and inflammation
2022

Successful treatment and prevention of the recurrence of refractory vernal keratoconjunctivitis with dupilumab.

Clinical &amp; experimental ophthalmology
2022

Conjunctival granuloma in vernal keratoconjunctivitis.

Journal francais d'ophtalmologie
2022

Cyclosporine A 0.1% Cationic Emulsion in Vernal Keratoconjunctivitis.

Journal of pediatric ophthalmology and strabismus
2022

Evidence of epithelial remodelling but not epithelial-mesenchymal transition by transcriptome profiling in vernal keratoconjunctivitis.

Allergy
2023

Prevalence of allergic sensitization with vernal keratoconjunctivitis: A systematic review with meta-analyses.

Acta ophthalmologica
2022

[PHARMACOTHERAPY FOR VERNAL KERATOCONJUNCTIVITIS].

Arerugi = [Allergy]
2022

Combination Therapy of 0.1% Fluorometholone and 0.05% Azelastine in Eyes with Severe Allergic Conjunctival Diseases: A Randomized Controlled Trial.

Journal of clinical medicine
2022

Effectiveness of a modified therapeutic protocol for the management of vernal keratoconjunctivitis based on Bonini's graded clinical severity.

Indian journal of ophthalmology
2022

Progressive Vision Loss in a Patient With Axenfeld-Rieger Syndrome.

Cureus
2022

Ocular allergy in children and adolescents.

Allergologia et immunopathologia
2023

Management of Vernal Keratoconjunctivitis in Children in the United Kingdom: A Review of the Literature and Current Best Practice Across Six Large United Kingdom Centers.

Journal of pediatric ophthalmology and strabismus
2022

Impact of screen exposure on pediatric vernal Keratoconjunctivitis: a survey during the COVID-19 pandemic in Italy.

Italian journal of pediatrics
2023

Examination of corneal microstructure in the quiescent phase of vernal keratoconjunctivitis using in vivo confocal microscopy.

European journal of ophthalmology
2022

Profile of ocular conditions from school eye screening in Southern India.

Indian journal of ophthalmology
Ver todos os 618 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Ceratoconjuntivite primaveril.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Ceratoconjuntivite primaveril

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Enigmatic Role of IL-31 in the Itch and Inflammation of Vernal Keratoconjunctivitis.
    Juntendo medical journal· 2026· PMID 41859225mais citado
  2. Effectiveness of Corticosteroid-Sparing Topical Treatments for Vernal Keratoconjunctivitis in Children: A Report by the American Academy of Ophthalmology.
    Ophthalmology· 2026· PMID 41801166mais citado
  3. Changing Strategies in Keratoplasty After Corneal Hydrops: From Penetrating to Lamellar Approaches - A Narrative Review.
    Clinical ophthalmology (Auckland, N.Z.)· 2026· PMID 41710166mais citado
  4. Corneal collagen cross-linking at diagnosis in pediatric keratoconus: A prospective study from the Indian Subcontinent.
    Indian journal of ophthalmology· 2026· PMID 41669774mais citado
  5. Factors associated with graft astigmatism after corneal transplantation for keratoconus.
    BMC ophthalmology· 2026· PMID 41652344mais citado
  6. Sexual Dimorphism in Allergic and Mast Cell-Associated Diseases.
    Clin Rev Allergy Immunol· 2026· PMID 41963721recente
  7. A red-eye presentation concerning for vernal keratoconjunctivitis: a case report.
    Allergy Asthma Clin Immunol· 2026· PMID 41943082recente
  8. Ultraviolet association with vernal keratoconjunctivitis with perilimbal pigmentation.
    Int J Ophthalmol· 2026· PMID 41924360recente
  9. Treatment of vernal keratoconjunctivitis simulating total limbal stem cell deficiency: a case report.
    BMC Ophthalmol· 2026· PMID 41913162recente
  10. Pediatric Vernal Keratoconjunctivitis (VKC): Current State and Future Directions-A Narrative Review of Clinical Features, Diagnostic Strategies, and Emerging Therapies.
    Children (Basel)· 2026· PMID 41897048recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:70476(Orphanet)
  2. MONDO:0019085(MONDO)
  3. GARD:7854(GARD (NIH))
  4. Busca completa no PubMed(PubMed)
  5. Q3686833(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Ceratoconjuntivite primaveril
Compêndio · Raras BR

Ceratoconjuntivite primaveril

ORPHA:70476 · MONDO:0019085
Prevalência
>1 / 1000
Herança
Not applicable
CID-10
H16.2 · Ceratoconjuntivite
CID-11
Ensaios
5 ativos
Início
Childhood
Prevalência
151.0 (Italy)
MedGen
UMLS
C0009773
Repurposing
30 candidatos
amlexanoxhistamine receptor modulator
antazolineantihistamine
azelastinehistamine receptor antagonist
+17 outros
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades